Treatment uptake and virological and immunological outcomes of cabotegravir+rilpivirine long-acting therapy versus dolutegravir or bictegravir-based regimens in people living with HIV: RESPOND HIV cohort collaboration

Conference Reports for NATAP

HIV Glasgow 2026
8-11 November


Treatment uptake and virological and immunological outcomes of cabotegravir+rilpivirine long-acting therapy versus dolutegravir or bictegravir-based regimens in people living with HIV: RESPOND HIV cohort collaboration

	Glasgow 2026 Nov 8-11 Alisa Timiryasova